{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1382825894241817346.json","@type":"Researcher","foaf:Person":[{"foaf:name":[{"@value":"Hiroyoshi Suzuki"}]}],"career":[{"institution":{"notation":[{"@value":"Sendai Medical Center"}]}}],"product":[{"@id":"https://cir.nii.ac.jp/crid/1362825894241817216","@type":"Article","productIdentifier":[{"@type":"DOI","@value":"10.1089/mab.2017.0050"},{"@type":"URI","@value":"https://journals.sagepub.com/doi/full-xml/10.1089/mab.2017.0050"},{"@type":"URI","@value":"https://journals.sagepub.com/doi/pdf/10.1089/mab.2017.0050"}],"notation":[{"@value":"Establishment of H\n                    <sub>2</sub>\n                    Mab-119, an Anti-Human Epidermal Growth Factor Receptor 2 Monoclonal Antibody, Against Pancreatic Cancer"}],"relation":[{"type":"creator"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1089/mab.2017.0050_JIsaKd4FF8TKDqiGK7Ez11Q4MSL"},{"@type":"OPENAIRE","@value":"doi_dedup___::1969605f7568bb29975313db44536421_JIsaKd4FF8TKDqiGK7Ez11Q4MSL"}]}